Hormone therapy may protect women from colorectal cancerApril 23rd, 2009 - 1:43 pm ICT by ANI
Washington, April 23 (ANI): A team of researchers led by Mayo Clinic scientists has found that hormone therapy use is linked to a significantly lower colorectal cancer risk.
However, the mechanisms for the apparent protective association are still unclear.
The study was designed to look at possible links between estrogen exposure and colon cancer molecular subtypes, to determine how these hormones might function as anti-cancer agents.
“In our large, prospective study, use of hormone therapy seemed to be beneficial with respect to reducing colorectal cancer risk - women who did use these drugs had a 28 percent lower incidence rate than women who did not use these drugs,” says the study’s lead author, David Limsui, M.D., a fellow in the Department of Gastroenterology at Mayo Clinic’s campus in Rochester, Minn.
“But we still don’t know how estrogen compounds work in cancer prevention, which is intriguing,” he added.
Women who reported using other hormone preparations, such as oral contraceptives, did not appear to derive any colorectal cancer prevention benefits.
“Based on our findings, we need to continue exploring the cancer pathways that might be affected by these hormones,” Limsui said.
In the study, the researchers examined tumour tissue from 553 colorectal cancer patients, specifically looking for associations between self-reported hormone use and a specific DNA methylation pattern, called the CpG island methylator phenotype, or BRAF gene mutations.
No associations were detected between hormone use and these molecular markers.
The study is being presented at the AACR 100th Annual Meeting 2009. (ANI)
- Older women with diabetes at higher colon cancer risk - May 03, 2010
- Menopausal hormone therapy 'ups ovarian cancer risk' - Nov 10, 2010
- Common bone drugs may cut colon cancer risk - Feb 16, 2011
- Oestrogen therapy 'causes ovarian cancer to grow five times faster' - Oct 21, 2010
- Estrogen helps women pile on pounds - Oct 06, 2011
- Higher levels of folate in RBCs linked to silenced tumor-suppressors - Dec 23, 2010
- Estrogen alone can cut risk of breast cancer - Dec 10, 2010
- New hope in the fight against melanoma - Dec 14, 2010
- Female sex hormone regulates weight - Oct 20, 2011
- Estrogen not linked to lung cancer mortality in postmenopausal women - Aug 14, 2010
- Aspirin may cut the risk of pancreatic cancer - Apr 05, 2011
- Hormone therapy linked to increased breast cancer risk: Study - Aug 11, 2010
- Decreased breast density over time means decreased breast cancer risk - Apr 21, 2010
- Conventional theory of modern drug design challenged - Oct 11, 2010
- Body fat distribution linked to a higher risk of ER-negative breast cancer - Dec 16, 2010
Tags: braf, cancer agents, cancer risk, colon cancer, colorectal, colorectal cancer patients, colorectal cancer prevention, cpg island, dna methylation, estrogen, gene mutations, hormone therapy, incidence rate, mayo clinic scientists, molecular markers, oral contraceptives, phenotype, prospective study, risk women, rochester minn